Insight Series

This fall, Gowling WLG is hosting a number of breakfast seminars as part of our Insight Series. The informative seminars will include discussions on recent legal developments, emerging trends and issues that will have an impact on your business.

Join Gowling WLG professional and Leader of the Life Sciences Group John Norman for an overview of the best patent and regulatory strategies for pharmaceutical and biologic medicines in Canada. This seminar will reveal the various strategies of how to maximize the protections and enforcement rights provided to Canadian innovators.

We will also discuss a few changes to the patent and regulatory schemes that will be implemented as a result of the United States-Mexico-Canada Agreement.

This seminar is eligible for up to 1 hour toward the LSBC's CPD requirement.

Other seminars in the series:

• Sept. 12 | New cannabis products: Regulatory and IP considerations for edibles, topicals and extracts
• Sept. 25 | Protecting your AI investment using patent applications
• Oct. 16 | Data protection: What Canadian companies need to know about operating in or trading with the European Union
• Nov. 14 | Trends in international patent development